SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001126234-18-000045
Filing Date
2018-03-13
Accepted
2018-03-13 17:53:29
Documents
1
Period of Report
2018-03-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_152097799512360.html 4  
1 FORM 4 wf-form4_152097799512360.xml 4 5512
  Complete submission text file 0001126234-18-000045.txt   6886
Mailing Address 2503 SOUTH LOOP DRIVE SUITE 5100 AMES IA 50010
Business Address 2503 SOUTH LOOP DRIVE SUITE 5100 AMES IA 50010 515-296-5555
NEWLINK GENETICS CORP (Issuer) CIK: 0001126234 (see all company filings)

IRS No.: 421491350 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NEWLINK GENETICS CORP. 2503 SOUTH LOOP DR., SUITE 5100 AIMES IA 50010
Business Address
Vahanian Nicholas N. (Reporting) CIK: 0001512114 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35342 | Film No.: 18687671